The 18-month extension of the GATHER2 trial indicated continued benefit for patients receiving avacincaptad pegol, with ...
I modified a printer a few years ago to handle multiple filaments, but I will admit it was more or less a stunt. It worked, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results